Joshua Omale, Pediatric Oncology Advocate, Innovation Council Member at Coalition Against Childhood Cancer (CAC2), shared a post on LinkedIn:
“Cancer control requires governance, not just medicine.
Cancer control does not fail because we lack drugs. It fails when governance is weak.
Where governance is strong:
- budgets align with burden
- prevention is financed
- referral systems are monitored
- data informs decisions
- accountability exists across levels
Where governance is weak:
- plans remain on paper
- funding is fragmented
- programs compete instead of coordinate
- outcomes vary by geography and income
Cancer systems do not improve by chance. They improve when leadership sets direction, aligns actors, and enforces follow-through.
Medicine treats disease. Governance determines whether treatment arrives in time.
Cancer control is ultimately a governance test.”
Other articles featuring Joshua Omale on OncoDaily.